Gelonghui, October 14 | The Hong Kong Exchange announced plans to launch futures on the Hang Seng Biotechnology Index, further enhancing its expanding derivatives ecosystem. The new futures contracts will begin trading on November 28, 2025, and will be benchmarked against the Hang Seng Biotechnology Index, focusing on one of the fastest-growing and most dynamic sectors. This provides investors with precise risk management tools and complements the Hong Kong Exchange’s existing biotech-related products and flagship stock index derivatives portfolio.